Follow us on:

Linkedin Facebook

One Health Group plc : Soaring NHS demand drives continued growth and dividends (VIDEO)

One Health Group plc (AQSE:OHGR) CEO Adam Binns joins DirectorsTalk Interviews to provide an overview of the company progress its making.

In this interview CEO Adam Binns gives us an overview of the company, talks us through the financial highlights for the six months to 30 September 2023, talks us through some of the operational metrics, explains what’s driving that growth, and how they are supporting it and lets us know what investors can expect in terms of growth plans for 2024. Adam concludes with his thoughts on why investors might want to consider this company as a addition to their portfolio.

One Health Group PLC (AQSE:OHGR) are a team of Consultant Surgeons and Healthcare managers working with the NHS to provide faster, local and expert care in Orthopaedics, Spinal, General Surgery and Gynaecology.

Find more news, interviews, share price & company profile here for:

Share this interview

Twitter
LinkedIn
Facebook
Email
WhatsApp
One Health Group plc : Soaring NHS demand drives continued growth and dividends (VIDEO)

Other Interviews

More News

Search

Useful links

Disclaimer

You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular stock, share, security, portfolio of securities, transaction, investment strategy, or other matter. We openly disclose that we and our contributors may have interests in investments and/or providers of services referred to within the website and that we receive remuneration from certain of the companies referred to on this website.

© 2024 – DirectorsTalk Interviews. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.